Acutus Medical, Inc.
AFIB · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $6 | $33 | $98 |
| - Cash | $14 | $19 | $26 | $24 |
| + Debt | $36 | $38 | $39 | $45 |
| Enterprise Value | $23 | $25 | $46 | $119 |
| Revenue | $20 | $7 | $3 | $17 |
| % Growth | 181.4% | 136.4% | -82.4% | – |
| Gross Profit | $1 | -$3 | -$2 | -$16 |
| % Margin | 5% | -43.8% | -63% | -90.7% |
| EBITDA | $2 | -$5 | $35 | -$105 |
| % Margin | 11.2% | -74.4% | 1,161.5% | -608.9% |
| Net Income | -$10 | -$82 | -$40 | -$118 |
| % Margin | -47.4% | -1,139.9% | -1,307% | -681.7% |
| EPS Diluted | -0.32 | -2.81 | -1.39 | -4.11 |
| % Growth | 88.6% | -102.2% | 66.2% | – |
| Operating Cash Flow | -$32 | -$63 | -$85 | -$100 |
| Capital Expenditures | -$0 | -$0 | -$4 | -$10 |
| Free Cash Flow | -$32 | -$63 | -$89 | -$110 |